Skip to main content
People

Rosy Liao

Biotech Equity Research Associate, Guggenheim Securities

image
Graduation Year: 2023
Thesis: Inhibition of BCL-2 Disrupts Regulatory T Cell Stability
Advisor: James LaBelle